Teva can’t launch a generic Lupkynis until at least Dec. 7, 2036 under a settlement with Aurinia. Read more here.
$AUPH
Price history, market instrument context, member research, and related headlines in one place.
AUPH key statistics
NasdaqGMUSD
52-week range
$11.2167%$19.25
Latest session $16.11–$16.82Aurinia Pharmaceuticals Inc. (AUPH) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $16.61, up $0.25 (1.53%) from the previous close of $16.36. It has traded between $16.11 and $16.82 in the latest session. Over the past year it has ranged from $11.21 to $19.25, leaving it in the upper half of its 52-week range (67%). Reported volume for the session was 1.2M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Aurinia Pharma earnings up next as growth momentum faces test — See source for full details.
Loading $AUPH research…